SALVAGE THERAPY: Options continue to expand for
patients who are resistant to most available antiretrovirals. Since the
introduction of HAART, the incidence of treatment failure has actually
been falling. Plus, there is a bevy of new drugs flowing through the
antiretroviral pipeline, and physicians' ability to individually tailor
HAART regimens is improving. This comprehensive report of recent research related to salvage therapy, written by Dr. Keith Henry, provides the latest word on this challenging subject.
SWITCHING THERAPY: Looking for an in-depth
discussion of HIV treatment switching and simplification studies
presented at CROI 2005? Edwin DeJesus, M.D., analyzes key switch/simplification presentations from CROI, while David Wohl, M.D., provides select case studies with relevance to clinicians and other healthcare providers.
More of the latest coverage>>
The Body's CROI 2005 coverage will include a wide array of individual presentations and symposia, as well as summaries of some of the hottest topics in HIV research.
For more information on CROI 2005, please visit the conference's Web site. You may also view the conference's program online.
Funding for coverage of this conference is provided, in part, by unrestricted educational grants from Abbott Laboratories, Boehringer Ingelheim and GlaxoSmithKline.
All coverage is © 2005 Body Health Resources Corporation.